ask="18.99"
ask_size="100"
average_daily_volume="42966"
bid="N/A"
bid_size="N/A"
book_value="5.83"
change="-0.48"
change_from_200_day_moving_average="-0.47"
change_from_50_day_moving_average="-2.00"
change_from_52_week_high="-7.56"
change_From_52_week_low="8.78"
change_in_percent="-2.49%"
close="18.80"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-13.50"
ebitda="-25.94M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="-0.61"
eps_estimate_next_year="-2.23"
ex_dividend_date="N/A"
float_shares="6898000"
high="19.89"
high_52_weeks="26.36"
last_trade_date="1/30/2017"
last_trade_price="18.80"
last_trade_size="2322"
last_trade_time="4:00pm"
low="18.40"
low_52_weeks="10.02"
market_capitalization="314.22M"
moving_average_200_day="19.27"
moving_average_50_day="20.80"
name="Protagonist Therapeutics
Inc."
notes="N/A"
one_year_target_price="31.00"
open="19.29"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-2.44%"
percent_change_from_50_day_moving_average="-9.60%"
percent_change_from_52_week_high="-28.68%"
percent_change_from_52_week_low="+87.62%"
previous_close="19.28"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.31"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="16714000"
short_ratio="4.09"
stock_exchange="NGM"
symbol="PTGX"
volume="16297"
weeks_range_52="10.02 - 26.36"
